C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Sirnaomics Enters Partnership with Walvax Biotechnology to Co-Develop Its Antiviral RNAi Therapeutic Product Candidate STP702

Friday, April 30, 2021

Sirnaomics Biopharmaceuticals Suzhou Co Ltd a subsidiary of Sirnaomics Inc a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer fibrotic diseases and viral infections

Brooklyn ImmunoTherapeutics Acquires License for mRNA Technology Platform to Develop Genetically Edited Cells to Treat Multiple Cancers, Blood and Other Disorders

Friday, April 30, 2021

Brooklyn ImmunoTherapeutics LLC announced it has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics Limited pursuant to an exercise of a previously announced option

Pfizer Acquires Amplyx Pharmaceuticals

Thursday, April 29, 2021

Pfizer Inc announced that it has acquired Amplyx Pharmaceuticals Inc a privatelyheld company dedicated to the development of therapies for debilitating and lifethreatening diseases that affect people with compromised immune systems

ESSA Pharma Announces Clinical Collaboration Agreement with Bayer to Evaluate the Combination of EPI-7386 and Darolutamide

Thursday, April 29, 2021

ESSA Pharma Inc a clinicalstage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer today announced that the Company has entered into a clinical trial collaboration and supply agreement with Bayer

Geneseeq and AstraZeneca Collaborate to Build Guangzhou Bio-Diagnostics Innovation Center

Wednesday, April 28, 2021

Geneseeq Technology Inc a precision oncology diagnostics company and AstraZeneca a global biopharmaceutical company are excited to announce their strategic collaboration to establish a BioDiagnostic Innovation Center in Guangzhou China

LogicBio Therapeutics Announces Strategic Collaboration and Option Agreement with CANbridge Pharmaceuticals Leveraging Gene Editing and Gene Delivery Platforms

Wednesday, April 28, 2021

LogicBio Therapeutics Inc a clinicalstage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood announced a strategic collaboration

Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific

Tuesday, April 27, 2021

Pieris Pharmaceuticals Inc and Boston Pharmaceuticals announced that the companies have entered into an exclusive product license agreement to develop PRS a BBGPC preclinical immunooncology Anticalinantibody bispecific fusion protein

CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and Develop Allogeneic CAR-Macrophages

Tuesday, April 27, 2021

CARISMA Therapeutics Inc a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies announced it has established a multiyear scientific collaboration with Bruce Blazar

Samsung Biologics and TG Therapeutics Expand Collaboration for the Large Scale Manufacture of Ublituximab

Monday, April 26, 2021

Samsung Biologics the worlds leading contract development and manufacturing organization and TG Therapeutics announced an expansion of a largescale contract manufacturing deal for the supply of TG Therapeutics ublituximab an investigational antiCD mo...

Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing

Friday, April 23, 2021

Vertex Pharmaceuticals Incorporated and Obsidian Therapeutics announced that the two companies have entered into a strategic research collaboration and licensing agreement focused on the discovery of novel therapies that regulate gene editing for the...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations